370 related articles for article (PubMed ID: 26400067)
1. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.
Qu Q; Ma X; Zhao Y
Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Effect of α-Tocopheryl Succinate Delivered by Mitochondria-Targeted Mesoporous Silica Nanoparticles.
Qu Q; Ma X; Zhao Y
ACS Appl Mater Interfaces; 2016 Dec; 8(50):34261-34269. PubMed ID: 27998109
[TBL] [Abstract][Full Text] [Related]
3. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
Tambe P; Kumar P; Paknikar KM; Gajbhiye V
Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
[TBL] [Abstract][Full Text] [Related]
4. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
5. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
6. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
7. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
8. Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum.
Shahabi S; Döscher S; Bollhorst T; Treccani L; Maas M; Dringen R; Rezwan K
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26880-91. PubMed ID: 26562468
[TBL] [Abstract][Full Text] [Related]
9. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging.
He H; Meng S; Li H; Yang Q; Xu Z; Chen X; Sun Z; Jiang B; Li C
Mikrochim Acta; 2021 Apr; 188(5):154. PubMed ID: 33821295
[TBL] [Abstract][Full Text] [Related]
10. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy.
Wang B; Zhang K; Wang J; Zhao R; Zhang Q; Kong X
Colloids Surf B Biointerfaces; 2020 May; 189():110832. PubMed ID: 32070865
[TBL] [Abstract][Full Text] [Related]
11. Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier.
Mo J; He L; Ma B; Chen T
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6811-25. PubMed ID: 26911360
[TBL] [Abstract][Full Text] [Related]
12. Co-responsive smart cyclodextrin-gated mesoporous silica nanoparticles with ligand-receptor engagement for anti-cancer treatment.
Wu Y; Xu Z; Sun W; Yang Y; Jin H; Qiu L; Chen J; Chen J
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109831. PubMed ID: 31349481
[TBL] [Abstract][Full Text] [Related]
13. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
[TBL] [Abstract][Full Text] [Related]
14. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
[TBL] [Abstract][Full Text] [Related]
15. N-Doped graphene quantum dot@mesoporous silica nanoparticles modified with hyaluronic acid for fluorescent imaging of tumor cells and drug delivery.
Gui W; Zhang J; Chen X; Yu D; Ma Q
Mikrochim Acta; 2017 Dec; 185(1):66. PubMed ID: 29594582
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
Giret S; Wong Chi Man M; Carcel C
Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
[TBL] [Abstract][Full Text] [Related]
17. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
18. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
[TBL] [Abstract][Full Text] [Related]
20. Combination of Nucleic Acid and Mesoporous Silica Nanoparticles: Optimization and Therapeutic Performance In Vitro.
Juneja R; Vadarevu H; Halman J; Tarannum M; Rackley L; Dobbs J; Marquez J; Chandler M; Afonin K; Vivero-Escoto JL
ACS Appl Mater Interfaces; 2020 Sep; 12(35):38873-38886. PubMed ID: 32805923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
